Neus Virgili Bernado
Corporate Officer/Principal presso ORYZON GENOMICS S.A.
Profilo
Neus Virgili Bernado is currently the Chief Intellectual Property Officer at Oryzon Genomics SA since 2011.
Prior to this, Neus worked as the Chief Patent Officer & Head-Legal Affairs at Palau Pharma SA. Neus completed an undergraduate degree from the University of Barcelona in 1990.
Posizioni attive di Neus Virgili Bernado
| Società | Posizione | Inizio |
|---|---|---|
| ORYZON GENOMICS S.A. | Corporate Officer/Principal | 01/09/2011 |
Precedenti posizioni note di Neus Virgili Bernado
| Società | Posizione | Fine |
|---|---|---|
Palau Pharma SA
 Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain. | General Counsel | - |
Formazione di Neus Virgili Bernado
| University of Barcelona | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ORYZON GENOMICS S.A. | Health Technology |
| Aziende private | 1 |
|---|---|
Palau Pharma SA
Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain. | Health Technology |
- Borsa valori
- Insiders
- Neus Virgili Bernado
